Page 5 - Mannkind Afrezza News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mannkind afrezza. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mannkind Afrezza Today - Breaking & Trending Today

MannKind (NASDAQ:MNKD) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of MannKind (NASDAQ:MNKD – Free Report) in a report issued on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Other analysts have also recently issued research reports about the stock. Cantor Fitzgerald boosted their price target on shares of MannKind from $6.50 to $7.50 and […] ....

Michael Castagna , David Thomson , Alfrede Mann , Raymond James Associates , Hightower Advisors , Securities Exchange Commission , Cantor Fitzgerald , Us Bancorp , Raymond James Financial Services Advisors Inc , International Assets Investment Management , Mannkind Corp , Free Report , Exchange Commission , Assets Investment Management , James Financial Services Advisors , Tower Advisors , Get Free Report , Mannkind Daily , Nasdaq Mnkd , Initiated Coverage , Stocknews Com ,

MannKind (NASDAQ:MNKD) PT Raised to $7.50

MannKind (NASDAQ:MNKD – Get Free Report) had its price target upped by investment analysts at Cantor Fitzgerald from $6.50 to $7.50 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has an “overweight” rating on the biopharmaceutical company’s stock. Cantor Fitzgerald’s target price indicates a potential upside of 41.78% from […] ....

Michael Castagna , Alfrede Mann , Stevenb Binder , Cantor Fitzgerald , Securities Exchange Commission , Cetera Advisor Networks , Topco Ltd , Mannkind Company Profile , First Horizon Advisors Inc , Mannkind Corp , Cetera Advisors , International Assets Investment Management , Get Free Report , Kind Stock Down , Exchange Commission , Assets Investment Management , Horizon Advisors , Mannkind Daily , Nasdaq Mnkd , Boost Price Target ,

MannKind (NASDAQ:MNKD) Price Target Increased to $7.50 by Analysts at Cantor Fitzgerald

MannKind (NASDAQ:MNKD – Get Free Report) had its target price upped by equities research analysts at Cantor Fitzgerald from $6.50 to $7.50 in a note issued to investors on Tuesday, Benzinga reports. The firm currently has an “overweight” rating on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price target suggests a potential upside of 41.78% from […] ....

Michael Castagna , Stevenb Binder , Alfrede Mann , Proshare Advisors , Charles Schwab Investment Management Inc , Securities Exchange Commission , Great West Life Assurance Co , Cetera Advisors , Mannkind Corp , Cetera Advisor Networks , Mannkind Company Profile , Cantor Fitzgerald , Get Free Report , Exchange Commission , West Life Assurance , Share Advisors , Advisor Networks , Charles Schwab Investment Management , Schwab Investment Management , Mannkind Daily , Nasdaq Mnkd , Boost Price Target ,

MannKind (NASDAQ:MNKD) Reaches New 1-Year High Following Analyst Upgrade

Shares of MannKind Co. (NASDAQ:MNKD – Get Free Report) hit a new 52-week high on Wednesday after Cantor Fitzgerald raised their price target on the stock from $6.50 to $7.50. Cantor Fitzgerald currently has an overweight rating on the stock. MannKind traded as high as $5.75 and last traded at $5.64, with a volume of […] ....

United States , Michael Castagna , Stevenb Binder , Alfrede Mann , Emerald Mutual Fund Advisers , Mannkind Corp , Cantor Fitzgerald , Mannkind Co , Securities Exchange Commission , Connor Clark Lunn Investment Management Ltd , Get Free Report , Exchange Commission , Lunn Investment Management , State Retirement System , Emerald Mutual Fund Advisers Trust , Mutual Fund Advisers Trust , Mannkind Daily , Nasdaq Mnkd ,

Comparing MannKind (NASDAQ:MNKD) & Greenwich LifeSciences (NASDAQ:GLSI)

MannKind (NASDAQ:MNKD – Get Free Report) and Greenwich LifeSciences (NASDAQ:GLSI – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings. Valuation & Earnings This table compares MannKind and […] ....

United States , Alfrede Mann , Greenwich Lifesciences Inc , Mannkind Corp , Norwell Inc , Get Free Report , Greenwich Lifesciences , Greenwich Lifescience , Given Greenwich Lifescience , Mannkind Daily , Nasdaq Mnkd , Stock Comparison , Stock Analysis ,